Azotobacter vinelandii, grown with ammonium as a nitrogen source, was shown to possess an active transport system which could concentrate ammonium 44 to 58 fold. Ammonium uptake was inhibited by the glutamate analog methionine sulfone. The properties of the ammonium uptake system (transport and metabolism) were investigated using the ammonium analog methylammonium. The uptake of methylammonium was inhibited by arsenate indicating that phosphate bond energy was required. Methylammonium uptake was also inhibited by the electron transport inhibitor, cyanide, and the uncoupler, carbonyl cyanide- m-chlorophenyl hydrazone. However, it was shown that these agents served to deplete ATP pools in A. vinelandii. Uptake of methylammonium was sensitive to a Tris-Mg⁺⁺ shock treatment suggesting the possible involvement of a periplasmic binding protein, however, methylammonium-binding activity was not found in periplasmic extracts. A. vinelandii was shown to exhibit a positive chemotactic response toward ammonium as well as acetate, glucose and sucrose. Comparison of outer membrane proteins from nitrogen-fixing cells and ammonium-grown cells revealed the production of a 44,000 dalton protein in membranes from nitrogen-fixing cells. Inner membranes from nitrogen-fixing cells contained a 41,000 dalton protein which was present in low amounts in the membranes of ammonium-grown cells. It was shown that the outer membranes of ammonium-grown cells contained a major protein which was "heat modifiable" in that its mobility on sodium dodecyl sulfate-polyacrylamide gel electrophoresis was determined by the temperature of solubilization prior to electrophoresis. Methylammonium was shown to be metabolized to N-methylglutamine. Strain JK301, an L-methionine-D,L-sulfoximine-resistant mutant of A. vinelandii, was unable to catalyse N-methylglutamine synthesis in vivo or in cell-free extracts and lacked detectable methylammonium uptake activity. Glutamine synthetase in cell-free extracts of JK301 had a Km for glutamate approximately three-fold higher and a Vmax approximately fourfold lower than enzyme from the wild type strain. It was concluded that methylammonium uptake reflects, in part, metabolism to N-methylglutamine by glutamine synthetase. / Science, Faculty of / Microbiology and Immunology, Department of / Graduate

Philosophiae Doctor - PhD / Background: Oropharyngeal candidiasis, caused by the fungus Candida, is the most common opportunistic infection affecting the quality of life of immunocompromised patients. Fluconazole is widely used as the first line of treatment for fungal infections. However, the inappropriate and misguided use of the drug has led to the evolvement of fluconazole-resistant Candida organisms. This arising resistance resulted in the urgent need for the development of new antimicrobial drugs. The aim of the present study was to investigate the antifungal action of K21, a novel antimicrobial quarternary ammonium compound, on fluconazole-resistant Candida species.

Master of Science / Food Science / Kelly J. K. Getty / Dry-processing environments are particularly challenging to clean and sanitize because water introduced into systems not designed for wet cleaning can favor growth and establishment of pathogenic microorganisms such as Salmonella. The objective was to determine the efficacy of isopropyl alcohol quaternary ammonium (IPAQuat) formula and carbon dioxide (CO[subscript]2) sanitizer system for eliminating Enterococcus faecium and Salmonella on food contact surfaces. Coupons of stainless steel and conveyor belting material used in dry-processing environments were spot-inoculated in the center of 5 × 5 cm coupons with approximately 7.0 log CFU/ml of E. faecium and up to 10 log CFU/ml of a six-serotype composite of Salmonella and subjected to IPAQuat-CO[subscript]2 sanitation treatments using exposure times of 30 s, 1 or 5 min. After sanitation treatments, wet coupons were swabbed for post-treatment survivors. Preliminary experiments included coupons which were soiled with a flour and water solution prior to inoculation and subsequent sanitation treatments. For the main study, inoculated surfaces were soiled with a breadcrumb flour blend and allowed to sit on the lab bench for a minimum of 16 h before sanitation. Preliminary results showed that IPAQuat-CO[subscript]2 sanitizing system was effective in reducing approximately 3.0 logs of E. faecium and Salmonella from clean and soiled surfaces after 1 min exposure but higher initial inoculum levels were needed to demonstrate >5 log reductions. For the main study, pre-treatment Salmonella populations were approximately 7.0 log CFU/25 cm[superscript]2 and post-treatment survivors were 1.3, < 0.7 (detection limit), and < 0.7 log CFU/25 cm[superscript]2 after 30 s, 1 or 5 min sanitizer exposures, respectively, for both clean and soiled surfaces. Treatment with IPAQuat-CO[subscript]2 sanitation system using 30 s sanitizer exposures resulted in 5.7 log CFU/25 cm[superscript]2 reductions whereas, greater than 6.0 log CFU/25 cm[superscript]2 reductions were observed for sanitizer exposures of 1 and 5 min. The IPAQuat-CO[subscript]2 sanitation system reduced 6 logs CFU/25 cm[superscript]2 of Salmonella with sanitizer exposure times of at least 1 min. The IPAQuat-CO[subscript]2 system would, therefore, be an effective sanitation system to eliminate potential contamination from Salmonella on food contact surfaces and have application in facilities that process dry ingredients or low-moisture products.

High strength wastewater (HSWW) generated in food processing industries is characterized by high organic carbon and nitrogen content, and thus high oxygen demand. Biological nitrogen removal (BNR) is a technology widely used for the treatment of HSWW. Food processing facilities practice sanitation to keep food contact surfaces clean and pathogen-free. Benzalkonium chlorides (BACs) are cationic quaternary ammonium antimicrobial compounds (QACs) common in industrial antimicrobial formulations. BAC-bearing wastewater generated during sanitation applications in food processing facilities is combined with other wastewater streams and typically treated in BNR systems. The poor selectivity and target specificity of the antimicrobial BACs negatively impact the performance of BNR systems due to the susceptibility of BNR microbial populations to BAC. Objectives of the research were: a) assessment and quantification of the inhibitory effect of QACs on the microbial groups, which mediate BNR in HSWW treatment systems while treating QAC-bearing HSWW; b) evaluation of the degree and extent of the contribution of QAC adsorption, inhibition, and biotransformation on the fate and effect of QACs in BNR systems. A laboratory-scale, multi-stage BNR system was continuously fed with real poultry processing wastewater amended with a mixture of three benzalkonium chlorides. The nitrogen removal efficiency initially deteriorated at a BAC feed concentration of 5 mg/L due to complete inhibition of nitrification. However, the system recovered after 27 days of operation achieving high nitrogen removal efficiency, even after the feed BAC concentration was stepwise increased up to120 mg/L. Batch assays performed using the mixed liquors of the BNR system reactors, before, during, and post BAC exposure, showed that the development of BAC biotransformation capacity and the acquisition of resistance to BAC contributed to the recovery of nitrification and nitrogen removal. Kinetic analysis based on sub-models representing BNR processes showed that BAC inhibition of denitrification and nitrification is correlated with BAC liquid-phase and solid-phase concentrations, respectively. Simulations using a comprehensive mathematical BNR model developed for this research showed that BAC degradation and the level of nitrification inhibition by BAC were dynamic brought about by acclimation and enrichment of the heterotrophic and nitrifying microbial populations, respectively. The fate and effect of BACs in the BNR system were accurately described when the interactions between adsorption, inhibition, and resistance/biotransformation were considered within the conditions prevailing in each reactor. This work is the first study on the fate and effect of antimicrobial QACs in a continuous-flow, multi-stage BNR system, and the first study to quantify and report parameter values related to BAC inhibition of nitrification and denitrification. Results of this study enable the rational design and operation of BNR systems for the efficient treatment of QAC-bearing wastewater. The outcome of this research provides information presently lacking, supporting the continuous use of QACs as antimicrobial agents in food processing facilities, when and where needed, while avoiding any negative impacts on biological treatment systems and the environment.

Antibacterial effectiveness in vitro of the original quaternary ammonium compounds that were synthesized in the Laboratory of Biologically active substances was determined and the dependence of this activity upon chemical structure of the compound was established. Also generalisations have been made concerning the regularity of this dependency, the effectiveness of the compounds was compared to benzalkonium chloride, their advantages and disadvantages were discussed. Acute toxicity of the most effective compound was established and compared to that of benzalkonium chloride. It was found that these compounds showed good antibacterial activity against Gr+ and Gr- bacteria and low toxicity, thus this original data was summarized in the patent Nr. 4712. For the first time it was found that upon disintegration of quaternary methenamonium compounds new quaternary ammonium compounds, aldehydes and ammonia are produced. The first two of the three show further antimicrobic activity. Using quaternary ammonium salts and cholrhexydine a biocide for disinfection was created. The created biocide was tested for effectiveness when used for disinfection of air in the premises, horizontal and vertical surfaces. The compound was used in the form of aerosols and electro-aerosols. The research data showed that strong concentrations of Dezinfektas IV are necessary (up to 30%), but small amount of the solution per volume is enough (20-30 ml/m3). Ten times higher concentration is needed for... [to full text]

Benzalkonium chlorides (BACs) are widely used, broad-spectrum disinfectants and frequently detected in the environment, even at toxic levels for life. Since such disinfectants can induce broad resistance capabilities, BACs may fuel the emergence of antibiotic resistance in the environment. A substantial body of literature has reported that exposure to BACs causes antibiotic resistance; yet, other studies suggest that the resistance linkage is rare, unsystematic, and/or clinically insignificant. Accordingly, whether or not disinfectant exposure mediates antibiotic resistance and, if so, what molecular mechanisms underlie the resistance link remains to be clearly elucidated. Further, understanding how microbial communities degrade BACs is important not only for alleviating the possible occurrence of antibiotic resistance but also reducing the potential risks to environmental and public health. An integrated strategy that combines metagenomics, metatranscriptomics, genetics, and traditional culture-dependent approaches was employed to provide novel insights into these issues. The integrative approach showed that a microbial community exposed to BACs can acquire antibiotic resistance through two mechanisms: i) horizontal transfer of previously uncharacterized efflux pump genes conferring resistance to BACs and antibiotics, which were encoded on a conjugative plasmid and co-selected together upon BACs and ii) selective enrichment of intrinsically multi-drug resistant organisms. Further, a microbial community adapts to BAC exposure via a variety of mechanisms, including selective enrichment of BAC-degrading species and amino acid substitutions and horizontal transfer of genes related to BAC resistance and degradation. The metatranscriptomic data suggests that the BAC-adapted microbial community metabolized BACs by cooperative interactions among its members. More specifically, Pseudomonas nitroreducens cleaved (i.e., dealkylated) BACs, metabolized the alkyl chain (the dealkylated product of BACs), and released benzyldimethylamine (the other product of BACs), which was further metabolized by other community members (e.g., Pseudomonas putida). Collectively, this study demonstrates the role of BACs in promoting antibiotic resistance and advances current understanding of a microbial community degrading BACs. The results of this work have important implications for (appropriate) usage of disinfectants and for assessing, predicting, and optimizing biological engineering processes treating BAC-bearing waste streams.

Quaternary ammonium compounds (QACs) are ubiquitous contaminants found worldwide in both engineered and natural systems. QACs are toxic to aquatic organisms and cause co-selection for antibiotic resistance, thus providing a reservoir of antibiotic-resistant bacteria, as well as antibiotic resistance genes in QAC-polluted environments. The objectives of the research presented here were to: a) systematically assess the fate and toxicity of QACs using quantitative structure-activity relationships (QSAR); b) evaluate the biotransformation potential of QACs under aerobic, anoxic and anaerobic conditions; and c) assess the potential toxicity of QACs biotransformation products. Nine QACs, belonging to three homologous groups -- monoalkonium, dialkonium and benzalkonium chlorides -- were the target QACs. The QACs critical micelle concentration (CMC) was determined. Then, the CMC was used as a descriptor to derive relationships between QAC structure and partitioning to biosolids as well as acute Microtox® toxicity. QACs with low CMCs had a relatively high adsorption affinity for biosolids and a lower toxicity than QACs with higher CMCs, which suggests that QACs that are more mobile and more (bio)available are more toxic. The biotransformation potential of benzalkonium chlorides (BAC) -- the most commonly used QACs found in engineered and natural biological systems -- under aerobic, methanogenic, nitrate reducing, and fermentative conditions was evaluated using bioenergetics and batch bioassays. The aerobic BAC biotransformation involved sequential dealkylation and debenzylation steps resulting in the formation of benzyl dimethyl amine, and dimethyl amine, respectively. The bacterial community involved in the aerobic BAC degradation was mainly composed of species belonging to the Pseudomonas genus. All QACs tested were recalcitrant under methanogenic conditions and inhibited methanogenesis at and above 25 mg QAC/L. Under nitrate reducing and fermentative conditions, BAC was transformed to alkyldimethyl amines via an abiotic reaction known as modified Hofmann degradation and a biotic reaction known as fumarate addition, respectively. Both reactions are based on a mechanism known as nucleophilic substitution. The discovery of BAC transformation by the above mentioned two reactions is the first ever report to document QAC transformation under anoxic/anaerobic conditions and delineate the transformation pathway.

The immune defense is geared to protect against a tremendous array of invaders. The ultimate goal of the immune system is to induce effective and balanced inflammatory responses that enable the efficient elimination of possible threats while avoiding both immunodeficiency and autoimmunity. The skewness towards inflammatory responses causing excessive collateral damage could lead to diverse autoimmune conditions. These conditions could be organ-specific or result from systemic immune dysregulations called systemic autoimmunity. The multifaceted nature and the intricate clinical heterogeneity of systemic autoimmune conditions indicate a strong influence of environmental factors on their immunopathogenesis, where environmental factors could either hinder or contribute to autoimmune development. We focused our research on deciphering the complex effects of environmental factors on the immunopathogenesis of systemic immune dysregulation, taking systemic lupus erythematosus (SLE or Lupus) as a model of systemic autoimmunity. SLE is one of the most mysterious autoimmune disorders with no known cure. In SLE, breaching of tolerance to self-antigens and the subsequent persistent inflammation and collateral tissue damage in multiple organs lead to very diverse clinical manifestations. These manifestations are a result from the interplay between multiple genetic susceptibilities and diverse environmental factors. To date, management plans for SLE are based on non-selective immunosuppressants that could impose significant side effects including increased risks of infection and infection-related mortalities. In parallel, environmental factors and the quality of life could significantly impact SLE management strategies. Therefore, delineating the immunomodulatory capacities of environmental factors would likely unravel more effective management strategies for SLE patients. The current research aims to investigate the central hypothesis that dietary and hygienic components modulate the immune dysregulations of SLE in a tissue- and disease stage-specific manner. We have focused on uncovering the complex effects of Vitamin A (VA) as an essential micronutrient with very diverse immunomodulatory capacities, and quaternary ammonium compound (QAC)-based disinfectants as ubiquitously used disinfectants that have been linked to immunotoxicity, on the immunopathogenesis of SLE. Due to the strong female bias of SLE where women especially of childbearing age are more prone to lupus, we have focused our research on delineating how these diverse factors shape the immunopathogenesis of SLE in female mice only. The first project dissected the immunomodulatory effects of VA, a potent immunomodulatory dietary component. Notably, VA exerts its function through a predominant metabolite known as all-trans-retinoic acid (tRA) that, as we have previously shown, has paradoxical and tissue-specific implications on lupus inflammation. Here, we utilized a pristane-induced model of lupus to investigate the disease stage-dependent effects of tRA. Oral supplementation of tRA was given either before pristane induction of lupus from weaning (3 weeks) to 3 months of age or after pristane induction of lupus from 3 to 9 months of age. We found that tRA treatment mediated disease stage-dependent effects and differentially affected the lupus-associated kidney inflammation (lupus nephritis) when given at the initiation vs. continuation phase of lupus. Unlike tRA treatment during active disease, pre-pristane treatment with tRA aggravated glomerulonephritis through potentiating leukocyte activation and trafficking to the kidney and augmenting renal pro-fibrotic signals. Post-pristane tRA treatment, on the other hand, exerted immunosuppressive functions of decreasing circulatory and renal deposition of autoantibodies as well as suppressing the renal expression of proinflammatory cytokines and chemokines. Interestingly, both pre- and post-pristane treatments with tRA reversed the pristane-induced leaky gut and similarly modulated the gut microbiota, suggesting a gut microbiota-independent mechanism by which tRA affects the initiation vs. continuation phase of lupus. As tRA could be protective against lupus nephritis especially during the active disease stage, and previous reports had shown hypovitaminosis A (reduced serum retinol levels) proceeding SLE, we expanded our investigation to decipher whether VA deficiency (VAD) was a contributing factor for severe SLE and to delineate how VAD affected the initiation and/or the progression of lupus nephritis in genetically-prone conditions. For that purpose, we utilized the classical murine lupus-prone model, MRL/lpr, and initiated VAD either during the gestation or after weaning to reveal potential time-dependent effects. VAD exacerbated lupus nephritis by provoking severe neutrophilic tubulointerstitial nephritis, and accelerated renal failure. This was concomitant with significantly higher mortality in all VAD mice. Mechanistically, VAD enhanced early activation of plasma cells and augmented their autoantibodies production. In addition, VAD led to an enhanced expansion of pathogenic T lymphocytes. In parallel, VAD increased renal infiltration of conventional and plasmacytoid dendritic cells. Our findings establish VAD as a driving factor for lupus nephritis progression in genetically predisposed conditions. These findings emphasize the importance of monitoring VA levels in SLE patients and urge for VA supplementations for patients at higher risk for hypovitaminosis A, especially during the maternal-neonatal interface. Additionally, this project warrants further investigations to delineate the molecular targets through which VA modulates cellular functions as well as immunopathogenesis of lupus nephritis. The information obtained from these studies may also benefit women with other autoimmune conditions and will pave the way for VA supplementations to be tested in clinical trials. The second project investigated the effects of ambient exposure to QAC-based disinfectants on the progression of murine SLE in genetically prone mice. We compared the disease progression in MRL/Lpr mice that have been exposed to QACs vs. those kept under a complete QAC-free condition. QAC-based disinfectants CP-64 or Labsan 256 were used under QAC-exposed conditions, while ethanol was used in the QAC-free environment. We found that compared to QAC-free mice, ambient exposure of lupus-prone mice to QACs led to smaller spleens with no change in circulating autoantibodies or the severity of glomerulonephritis. This suggests that QACs may have immunosuppressive effects on lupus. Using a microfluidic device, we showed that ambient exposure to QACs reduced directional migration of bone marrow-derived neutrophils toward an inflammatory chemoattractant ex vivo. Consistent with this, we found decreased infiltration of neutrophils into the spleen. While bone marrow-derived neutrophils appeared to exhibit a pro-inflammatory profile, upregulated expression of PD-L1 was observed on neutrophils that infiltrated the spleen, which in turn interacted with PD-1 on T cells and modulated their fate. Specifically, QAC exposure hindered activation of splenic T cells and increased apoptosis of effector T-cell populations. Collectively, these results suggest that ambient QAC exposure decreases lupus-associated splenomegaly likely through neutrophil-mediated toning of T-cell activation and/or apoptosis. However, our findings also indicate that even ambient exposure could alter immune cell phenotypes, functions, and their fate. Further investigations on how QACs affect immunity under steady-state conditions are warranted. Collectively, the findings of this doctoral research suggest temporal and spatial effects of diet and hygiene on systemic autoimmunity and emphasize the strong influence of environmental factors toning cellular immune responses and subsequently shaping autoimmune outcomes. Our findings could pave the way for more personalized healthcare plans for autoimmune patients that take into consideration tissue involvement, disease stages, and the patient's lifestyle. / Doctor of Philosophy / The immune system is efficiently toned to discriminate between friends and foes. It effectively protects against a wide array of pathogens while at the same time avoiding attacking self-tissues. The inability of immune defenses to achieve this optimal discrimination could lead to the breakdown of tolerance to self in a wide range of autoimmune conditions. Diverse genetic susceptibilities are implicated in the development of autoimmunity. In parallel, during the recent decades, the tremendous increase in the prevalence of autoimmune conditions coincides with evolving dietary and hygiene styles in Westernized societies. This suggests a strong influence of environmental factors such as dietary and hygienic components on the way that the immune system works. Therefore, the current research investigates whether diet and hygiene modulate the immune dysregulations of lupus disease as a model for systemic autoimmunity; and if so, whether such effects are tissue- and/or disease stage-specific. We utilized different mouse models to delineate the mechanisms by which essential nutrients such as vitamin A (VA) and widely used disinfectant compounds known as quaternary ammonium disinfectants (QACs) modulate the systemic autoimmunity in lupus disease. We found that these modulators influence various aspects of the cellular immune responses including (1) leukocyte activation and subsequent expansion of pathogenic (disease contributing) lymphocytes, production of antibodies directed against self-tissue molecules (i.e., autoantibodies), and production of inflammatory mediators (i.e., cytokines and chemokines); (2) cell trafficking and their infiltration into the tissues; (3) signal transduction pathways that modulate cell fate (e.g., PD-1: PD-L1 signaling). Importantly, environmental modulation of autoimmunity during different stages of autoimmune development could significantly impact the disease outcome. VA treatment, for example, differentially modulates the progression of kidney inflammation when given during the initiation vs. progressive disease stages. Similarly, VA deficiency has the most prominent effects on worsening kidney inflammation under genetically prone conditions when the deficiency is initiated early and at the prenatal stage. In parallel, the effects of environmental factors are also tissue-specific. For example, ambient exposure to QAC-based disinfectants exerted immunosuppressive effects on lupus-associated inflammation of lymphoid tissues with no change in circulating autoantibodies or the severity of kidney inflammation. Collectively, the findings of this doctoral research delineated the cellular mechanisms through which environmental factors could shape autoimmune responses. Further studies will dig into the underlying molecular pathways. Ultimately, our research emphasizes the strong influence of exogenous factors on immunity and will pave the way for more effective healthcare management plans and benefit vulnerable populations affected by autoimmune conditions such as lupus.

Recirculating aquaculture offers a prospect for successful fish farming, but this form of aquaculture presents a great potential for pathogenic microorganisms to become established in the system through the formation of biofilms. Biofilms are capable of forming on all aquaculture system components, incorporating the various microflora present in the water. Pathogenic microorganisms released from the biofilms are capable of causing recurring exposure to disease in both fish and humans. With the increased consumption of raw and rare fish, the presence of these bacteria in or on the fish could lead to ingestion of pathogens. There is also the possibility of cross-contamination during processing. The objectives of this study were to increase the understanding of pathogen incorporation into biofilms in recirculating aquaculture systems and to determine the effectiveness of various sanitizers in eliminating biofilms. Seven freshwater and two saltwater facilities were sampled, with eight different types of materials tested. Pathogenic bacteria were identified using Bacteriological Analytical Manual methods and rapid commercial test kits. Most of the pathogenic bacteria identified were opportunistic organisms ubiquitous in an aquatic environment. The most significant human pathogens were Bacillus cereus, the Shigella species and the Vibrio species. The major piscine pathogens of concern were Photobacterium damsela, the Vibrio species, and Aeromonas hydrophila. The most significant variation in biofilm pathogens was observed between facilities and not construction material. Buna-N rubber, polyvinyl chloride (PVC), chlorinated PVC, glass, fiberglass and stainless steel disks were suspended in 79.2 liter (20 gallon) aquariums stocked with Nile tilapia (Oreochromus niloticus). The tanks were inoculated with a known amount of green fluorescent protein (GFP) modified Escherichia coli and samples were removed on days 1,3, 7 and 15. The modified E. coli were isolated on Luria Broth Agar and plate counts were performed under ultraviolet light. There was no significant difference in the growth of the surrogate pathogen on the different materials. The GFP E. coli was isolated in the largest numbers 24 hours after inoculation of the tanks, with an approximate 1-log decrease after day 1. Days 3, 7, and 15 showed equivalent growth of the target organism. Two sets of disks were suspended in another six 79.2 liter (20 gallon) aquariums. The tanks were inoculated with a known amount of the surrogate pathogen, GFP E. coli, and after 24 hours one set of disks was removed from each tank. The second set of disks was removed and treated by spraying with water, alkaline cleanser, sodium hypochlorite, quaternary ammonium compound, or peracetic acid. Ozone was bubbled directly into one tank to treat another set of disks. The modified E. coli were isolated and counted. Total aerobic plate counts and Enterobacteriaceae counts were performed. Statistical analysis indicated that the type of material had no significant affect on the effectiveness of the sanitizers. It was determined that sodium hypochlorite (99.4591 overall reduction) and peracetic acid (98.8461 % overall reduction) were the most effective sanitizers overall, and ozone (32.9332 % overall reduction) was the least effective. / Ph. D.

Compostos de amônio quaternário (QACs) têm sido amplamente utilizados como desinfetantes e antissépticos, sendo essenciais na prevenção e controle de infecções bacterianas na medicina humana e veterinária. Embora patógenos prioritários multirresistentes têm sido muito bem caracterizados quanto ao perfil de suscetibilidade e contexto genético da resistência aos antibióticos, dados de resistência aos QACs são limitados. Assim, o objetivo do presente estudo foi avaliar a atividade in vitro dos QACs de uso doméstico e hospitalar [cloreto de benzalcônio (BAC), cloreto de cetilpiridinio (CPC) e brometo de cetiltrimetilamônio (CTAB)], contra patógenos prioritários multirresistentes, identificando os principais genes de resistência associados. Foram estudadas 100 cepas multirresistentes previamente sequenciados usando as plataformas Illumina MiSeq e NextSeq representativas de diferentes hospedeiros (humanos e animais) e fontes (ambientes e alimentos). As cepas foram identificadas como Klebsiella pneumoniae (n= 24), Escherichia coli (n= 30); Pseudomonas aeruginosa (n= 10), Enterobacter spp, (n= 8), Acinetobacter baumannii (n= 11) e Salmonella spp. (n= 17). Genes de resistência aos QACs foram identificados in silico através do alinhamento dos contigs obtidos de cada cepa sequenciada com genes de referência obtidos do GenBank, utilizando o programa Geneious versão 8 (Biomatters Ltd). A identidade de cada gene foi analisada utilizando o programa BLASTx, no qual um critério baseado em &#8805;90% identidade resultou na identificação dos genes mdfA (77%), qacE (44%), qacE&#916;1 (43%), sugE(c) (29%), emrE (21%), qacA (19%), sugE(p) (5%), qacF (7%), qacH (7%) e qacL (7%) em 85 cepas; enquanto que 15 cepas não possuíam nenhum gene de resistência aos QACs. A concentração inibitória mínima (CIM) dos QACs para as 100 cepas foi determinada pelo método de microdiluição em caldo. Os resultados sugeriram que a resistência em patógenos prioritários circulando na interface humano-ambiente-animal não é restrita aos antibióticos, uma vez que a elevada ocorrência de genes qacE, qacE&#916;1 e mdfA poderia estar associada com uma redução da suscetibilidade para QACs. Consequentemente, a resistência aos QACs poderia também contribuir para a persistência e adaptação destes patógenos nos seres humanos e outros animais, assim como em ambientes impactados antropogenicamente. / Quaternary ammonium compounds (QACs) have been widely used as disinfectants and antiseptics, being applied as essential compounds in the prevention and control of bacterial infections in human-and veterinary hospital medicine. Although multiresistant priority pathogens have been well characterized with respect to their susceptibility profile and their genetic context of resistance for antibiotics, studies of resistance to QACs are limited. Thus, the objective of the present study was to evaluate the in vitro activity of QACs [(benzalkonium chloride (BAC), cetylpyridinium chloride (CPC) and cetyltrimethylammonium bromide (CTAB)] for household and hospital use against multiresistant priority pathogens, identifying the main resistance genes associated. A hundred multiresistant isolates (previously sequenced using the Illumina MiSeq and NextSeq platforms), representative of different hosts (humans and animals) and sources (environment and food) were studied. Isolates were identified as Klebsiella pneumoniae (n=24), Escherichia coli (n=30), Pseudomonas aeruginosa (n=10), Enterobacter spp. (n=8), Acinetobacter baumannii (n=11) and Salmonella spp. (n=17). In silico analysis for identification of genes conferring resistance to QACs were performed by aligning the contigs obtained from the strains with reference genes deposited in GenBank, using the Geneious version program (Biomatters Ltd). Similarities were analyzed using the BLASTx online program, considering the alignment criteria based on &#8805; 90% identity. The result of these analysis revealed the presence of the following QAC genes: mdfA (77%), qacE (44%), qacE&#916;1 (43%), sugE(c) (29%), emrE (21%), qacA (19%), sugE (p) (5%), qacF (7%), qacH (7%) e qacL (7%); while 15 strains showed no resistance genes for QACs. Determination of QACs minimum inhibitory concentration (MIC) for the 100 isolates, by the broth microdilution method. These results suggest that resistance to QACs in priority pathogens, circulating at the human-environment-animal interface, is not restricted to antibiotics, since the high occurrence of genes qacE, qacE&#916;1 and mdfA were associated with a reduced susceptibility to QACs. Consequently, resistance to QACs could also contribute to the persistence and adaptation of these pathogens in humans and othes animals, as well as in anthropogenically impacted environments.